US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
05 May, 2026, 09.04 PM IST
Pfizer launches new medication for migraine treatmentIn a significant breakthrough for migraine sufferers in India, Pfizer has launched Rimegepant ODT, an innovative oral tablet that dissolves...
17 Nov, 2025, 02.59 PM IST
Alembic Pharmaceuticals gets USFDA nod for generic migraine treatment injectionAlembic Pharmaceuticals has achieved a pivotal milestone with the final green light from the US health authority for its generic Sumatripta...
10 Nov, 2025, 01.32 PM IST
Research says blood flow changes in eyes can influence visual symptoms of migraineThe research employed a non-invasive imaging technique called optical coherence tomography angiography (OCTA) to observe alterations in ret...
08 Jan, 2024, 02.39 PM IST
A hand-worn device can provide you relief from migraine pain without medicine: Here is how it works, costHyderabad-based pharmaceutical company, Dr Reddy's Laboratories, has launched Nerivio, a revolutionary wearable therapy device for the trea...
17 Nov, 2023, 01.25 PM IST
Surgery could be the answer to severe headaches caused by migraineThere is at least a 50% reduction in frequency and intensity of pain, with surgical removal providing long-term relief.
13 Nov, 2017, 10.54 AM IST
Dr Reddy's may file two new drugs with FDA by 2019The city-based pharma company is expected to file the New Drug Application (NDA)with US Food and Drug Administration with regard the migrai...
20 Jun, 2017, 03.00 PM IST
Zydus Cadila gets USFDA nod to market migraine drugZydus Cadila has received the final approval from the USFDA to market Eletriptan Hydrobromide tablets, 20 mg (base) and 40 mg (base).
19 Jun, 2017, 04.58 PM IST
Alembic Pharma gets US FDA nod for anti-migraine drug"The company has received approval from the USFDA for its Abbreviated New Drug Application for Zolmitriptan Orally Disintegrating Tablets, ...
05 Dec, 2016, 11.27 AM IST
Ajanta Pharma gets USFDA nod for migraine pain relief drugAjanta Pharma has received final approval for its generic version of acute migraine pain relief drug Zolmitriptan tablets from the US healt...
24 May, 2016, 12.28 PM IST
Dr Reddy’s goes beyond generic products, gets nod for two branded drugsThe approvals have come at a time when Indian drug companies are facing the FDA’s ire for non-compliance of good manufacturing process.
02 Feb, 2016, 04.00 AM IST
Dr Reddy's gets USFDA nod for migraine injectionThe company has received an approval from the US Food and Drug Administration (USFDA) for ZembraceSymTouch injection, DRL said in a stateme...
29 Jan, 2016, 05.02 PM IST
Jubilant Life Sciences gets USFDA nod for migraine treatment drugJubilant Life Sciences announced approval from the US health regulator for its generic version of Merck's acute migraine treatment medicine.
20 Oct, 2015, 01.43 PM IST
Dr Reddy's files three new drug applications with USFDAOf them, the two NDAs are the first dermatology applications submitted to the US regulator that were fully developed leveraging in-house ca...
07 Apr, 2015, 11.31 PM IST
Aurobindo Pharma gets USFDA nod for anti-migraine tabletsThe product which was tentatively approved by the FDA earlier, is ready for launch, a statement from Aurobindo said.
01 Jan, 2013, 02.02 PM IST
- Sun Pharma gets USFDA approval for migraine injection
Sun Pharma said it has received the USFDA approval for the launch of its generic Sumatriptan Succinate injections in the American market.
23 Jun, 2011, 04.31 AM IST
- Govt to share Lupin's migraine
The government's Department of Science and Technology (DST) has committed over Rs 10 crore to support drug maker Lupin's two clinical devel...
27 Apr, 2007, 12.20 PM IST